378 related articles for article (PubMed ID: 24133624)
1. Gene expression of the IGF pathway family distinguishes subsets of gastrointestinal stromal tumors wild type for KIT and PDGFRA.
Beadling C; Patterson J; Justusson E; Nelson D; Pantaleo MA; Hornick JL; Chacón M; Corless CL; Heinrich MC
Cancer Med; 2013 Feb; 2(1):21-31. PubMed ID: 24133624
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of insulin-like growth factor 1 receptor and frequent mutational inactivation of SDHA in wild-type SDHB-negative gastrointestinal stromal tumors.
Belinsky MG; Rink L; Flieder DB; Jahromi MS; Schiffman JD; Godwin AK; von Mehren M
Genes Chromosomes Cancer; 2013 Feb; 52(2):214-24. PubMed ID: 23109135
[TBL] [Abstract][Full Text] [Related]
3. Succinate dehydrogenase-deficient GISTs are characterized by IGF1R overexpression.
Chou A; Chen J; Clarkson A; Samra JS; Clifton-Bligh RJ; Hugh TJ; Gill AJ
Mod Pathol; 2012 Sep; 25(9):1307-13. PubMed ID: 22555179
[TBL] [Abstract][Full Text] [Related]
4. Platelet-Derived Growth Factor Receptor-α Regulates Proliferation of Gastrointestinal Stromal Tumor Cells With Mutations in KIT by Stabilizing ETV1.
Hayashi Y; Bardsley MR; Toyomasu Y; Milosavljevic S; Gajdos GB; Choi KM; Reid-Lombardo KM; Kendrick ML; Bingener-Casey J; Tang CM; Sicklick JK; Gibbons SJ; Farrugia G; Taguchi T; Gupta A; Rubin BP; Fletcher JA; Ramachandran A; Ordog T
Gastroenterology; 2015 Aug; 149(2):420-32.e16. PubMed ID: 25865047
[TBL] [Abstract][Full Text] [Related]
5. Expression of the receptor for type i insulin-like growth factor (IGF1R) in gastrointestinal stromal tumors: an immunohistochemical study of 1078 cases with diagnostic and therapeutic implications.
Lasota J; Wang Z; Kim SY; Helman L; Miettinen M
Am J Surg Pathol; 2013 Jan; 37(1):114-9. PubMed ID: 22892600
[TBL] [Abstract][Full Text] [Related]
6. Expression of IGF-1 receptor in KIT/PDGF receptor-α wild-type gastrointestinal stromal tumors with succinate dehydrogenase complex dysfunction.
Nannini M; Astolfi A; Paterini P; Urbini M; Santini D; Catena F; Indio V; Casadio R; Pinna AD; Biasco G; Pantaleo MA
Future Oncol; 2013 Jan; 9(1):121-6. PubMed ID: 23252569
[TBL] [Abstract][Full Text] [Related]
7. Gastrointestinal stromal tumors - Summary of mutational status of the primary/secondary KIT/PDGFRA mutations, BRAF mutations and SDH defects.
Kalfusova A; Linke Z; Kalinova M; Krskova L; Hilska I; Szabova J; Vicha A; Kodet R
Pathol Res Pract; 2019 Dec; 215(12):152708. PubMed ID: 31708372
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor 1 receptor expression in wild-type GISTs: a potential novel therapeutic target.
Pantaleo MA; Astolfi A; Di Battista M; Heinrich MC; Paterini P; Scotlandi K; Santini D; Catena F; Manara MC; Nannini M; Maleddu A; Saponara M; Lolli C; Formica S; Biasco G
Int J Cancer; 2009 Dec; 125(12):2991-4. PubMed ID: 19672856
[TBL] [Abstract][Full Text] [Related]
9. High expression of the RNA-binding protein RBPMS2 in gastrointestinal stromal tumors.
Hapkova I; Skarda J; Rouleau C; Thys A; Notarnicola C; Janikova M; Bernex F; Rypka M; Vanderwinden JM; Faure S; Vesely J; de Santa Barbara P
Exp Mol Pathol; 2013 Apr; 94(2):314-21. PubMed ID: 23295309
[TBL] [Abstract][Full Text] [Related]
10. Low frequency of MAP kinase pathway alterations in KIT and PDGFRA wild-type GISTs.
Martinho O; Gouveia A; Viana-Pereira M; Silva P; Pimenta A; Reis RM; Lopes JM
Histopathology; 2009 Jul; 55(1):53-62. PubMed ID: 19614767
[TBL] [Abstract][Full Text] [Related]
11. Pediatric KIT wild-type and platelet-derived growth factor receptor alpha-wild-type gastrointestinal stromal tumors share KIT activation but not mechanisms of genetic progression with adult gastrointestinal stromal tumors.
Janeway KA; Liegl B; Harlow A; Le C; Perez-Atayde A; Kozakewich H; Corless CL; Heinrich MC; Fletcher JA
Cancer Res; 2007 Oct; 67(19):9084-8. PubMed ID: 17909012
[TBL] [Abstract][Full Text] [Related]
12. Patterns of deregulation of insulin growth factor signalling pathway in paediatric and adult gastrointestinal stromal tumours.
Italiano A; Chen J; Zhang L; Hajdu M; Singer S; DeMatteo RP; Antonescu CR
Eur J Cancer; 2012 Nov; 48(17):3215-22. PubMed ID: 22770876
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumors.
Tarn C; Rink L; Merkel E; Flieder D; Pathak H; Koumbi D; Testa JR; Eisenberg B; von Mehren M; Godwin AK
Proc Natl Acad Sci U S A; 2008 Jun; 105(24):8387-92. PubMed ID: 18550829
[TBL] [Abstract][Full Text] [Related]
14. Succinate dehydrogenase-deficient gastrointestinal stromal tumors.
Wang YM; Gu ML; Ji F
World J Gastroenterol; 2015 Feb; 21(8):2303-14. PubMed ID: 25741136
[TBL] [Abstract][Full Text] [Related]
15. [Molecular mechanisms of primary and secondary resistance, molecular-genetic features and characteristics of KIT/PDGFRA non-mutated GISTs].
Kalfusová A; Kodet R
Cesk Patol; 2017; 53(4):167-173. PubMed ID: 29227120
[TBL] [Abstract][Full Text] [Related]
16. A Duodenal SDH-Deficient Gastrointestinal Stromal Tumor in a Patient With a Germline SDHB Mutation.
Elston MS; Sehgal S; Dray M; Phillips E; Conaglen JV; Clifton-Bligh RJ; Gill AJ
J Clin Endocrinol Metab; 2017 May; 102(5):1447-1450. PubMed ID: 28324028
[TBL] [Abstract][Full Text] [Related]
17. An overview on molecular biology of KIT/PDGFRA wild type (WT) gastrointestinal stromal tumours (GIST).
Nannini M; Biasco G; Astolfi A; Pantaleo MA
J Med Genet; 2013 Oct; 50(10):653-61. PubMed ID: 23833252
[TBL] [Abstract][Full Text] [Related]
18. Succinate dehydrogenase deficiency is associated with decreased 5-hydroxymethylcytosine production in gastrointestinal stromal tumors: implications for mechanisms of tumorigenesis.
Mason EF; Hornick JL
Mod Pathol; 2013 Nov; 26(11):1492-7. PubMed ID: 23743927
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like Growth Factor (IGF) system and gastrointestinal stromal tumours (GIST): present and future.
Nannini M; Biasco G; Astolfi A; Urbini M; Pantaleo MA
Histol Histopathol; 2014 Feb; 29(2):167-75. PubMed ID: 24129766
[TBL] [Abstract][Full Text] [Related]
20. Gene duplication, rather than epigenetic changes, drives FGF4 overexpression in KIT/PDGFRA/SDH/RAS-P WT GIST.
Urbini M; Astolfi A; Indio V; Nannini M; Schipani A; Bacalini MG; Angelini S; Ravegnini G; Calice G; Del Gaudio M; Secchiero P; Ulivi P; Gruppioni E; Pantaleo MA
Sci Rep; 2020 Nov; 10(1):19829. PubMed ID: 33199729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]